Results
Opus Genetics Inc.
04/22/2026 | Press release | Distributed by Public on 04/22/2026 04:16
Proxy Results (Form 8-K)
| Item 5.07. |
Submission of Matters to a Vote of Security Holders.
|
At the 2026 annual meeting of stockholders (the "Annual Meeting") of Opus Genetics, Inc. (the "Company"), held on April 20, 2026, the Company's stockholders (i) elected nine directors to the board of directors of the Company, each to serve a one-year term until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation, or removal (the "Board Election Proposal"), (ii) ratified the appointment of Ernst & Young, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 (the "Auditor Ratification Proposal"), (iii) approved, on an advisory basis, the compensation of the Company's named executive officers (the "Say-On-Pay Proposal"), and (iv) approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's common stock from 125 million shares to 250 million shares (the "Stock Increase Proposal").
The results of the voting at the Annual Meeting are shown below:
Proposal 1 - Board Election Proposal:
|
Nominee
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
|||
|
Sean Ainsworth
|
35,063,423
|
169,848
|
12,043,097
|
|||
|
Dr. Jean Bennett
|
35,005,873
|
227,398
|
12,043,097
|
|||
|
Susan K. Benton
|
35,018,757
|
214,514
|
12,043,097
|
|||
|
Cam Gallagher
|
35,020,569
|
212,702
|
12,043,097
|
|||
|
Dr. Adrienne Graves
|
35,025,204
|
208,067
|
12,043,097
|
|||
|
Dr. George Magrath
|
35,054,118
|
179,153
|
12,043,097
|
|||
|
Dr. James S. Manuso
|
33,885,159
|
1,348,112
|
12,043,097
|
|||
|
Richard Rodgers
|
35,049,948
|
183,323
|
12,043,097
|
|||
|
Dr. Benjamin R. Yerxa
|
35,051,244
|
182,027
|
12,043,097
|
Proposal 2 - Auditor Ratification Proposal:
|
Votes For
|
Votes Against
|
Abstentions
|
||
|
46,844,680
|
315,324
|
116,364
|
Proposal 3 - Say-On-Pay Proposal:
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
|||
|
34,862,743
|
259,749
|
110,779
|
12,043,097
|
Proposal 4 - Stock Increase Proposal:
|
Votes For
|
Votes Against
|
Abstentions
|
||
|
45,360,642
|
1,486,247
|
429,479
|
Opus Genetics Inc. published this content on April 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 22, 2026 at 10:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]